Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
A Note from the Publisher
Biotech Transfer Week will cease publication with this issue. Thank you for your support of the newsletter during the last two and a half years.
BTW Editor Ben Butkus will be transitioning to GenomeWeb's free daily online news service to cover technology transfer, licensing, and IP trends in the life sciences tools and technologies market.
Please look for expanded coverage of these areas on GenomeWeb Daily News in the coming weeks.
New to GenomeWeb? Register quickly here for free access.